136 related articles for article (PubMed ID: 9548204)
1. In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease.
Tanaka E; Breimer DD
J Clin Pharm Ther; 1997 Aug; 22(4):237-49. PubMed ID: 9548204
[TBL] [Abstract][Full Text] [Related]
2. Clinical importance of non-genetic and genetic cytochrome P450 function tests in liver disease.
Tanaka E
J Clin Pharm Ther; 1998 Jun; 23(3):161-70. PubMed ID: 9831966
[TBL] [Abstract][Full Text] [Related]
3. Critical appraisal of 13C breath tests for microsomal liver function: aminopyrine revisited.
Pijls KE; de Vries H; Nikkessen S; Bast A; Wodzig WK; Koek GH
Liver Int; 2014 Apr; 34(4):487-94. PubMed ID: 24428683
[TBL] [Abstract][Full Text] [Related]
4. Trimethadione metabolism by human liver cytochrome P450: evidence for the involvement of CYP2E1.
Kurata N; Nishimura Y; Iwase M; Fischer NE; Tang BK; Inaba T; Yasuhara H
Xenobiotica; 1998 Nov; 28(11):1041-7. PubMed ID: 9879636
[TBL] [Abstract][Full Text] [Related]
5. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
von Mandach U; Jost G; Preisig R
Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
[TBL] [Abstract][Full Text] [Related]
6. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.
Frye RF; Branch RA
Br J Clin Pharmacol; 2002 Feb; 53(2):155-62. PubMed ID: 11851639
[TBL] [Abstract][Full Text] [Related]
8. The aminopyrine breath test.
Perri F; Pastore M; Annese V; Andriulli A
Ital J Gastroenterol; 1994; 26(6):306-17. PubMed ID: 7949268
[TBL] [Abstract][Full Text] [Related]
9. How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo?
Tanaka E; Kurata N; Yasuhara H
J Clin Pharm Ther; 2003 Jun; 28(3):157-65. PubMed ID: 12795773
[TBL] [Abstract][Full Text] [Related]
10. Assessment of cytochrome P450 activity by a five-drug cocktail approach.
Zhu B; Ou-Yang DS; Chen XP; Huang SL; Tan ZR; He N; Zhou HH
Clin Pharmacol Ther; 2001 Nov; 70(5):455-61. PubMed ID: 11719732
[TBL] [Abstract][Full Text] [Related]
11. Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis.
Bastien MC; Leblond F; Pichette V; Villeneuve JP
Can J Physiol Pharmacol; 2000 Nov; 78(11):912-9. PubMed ID: 11100940
[TBL] [Abstract][Full Text] [Related]
12. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1.
Ono S; Hatanaka T; Hotta H; Tsutsui M; Satoh T; Gonzalez FJ
Pharmacogenetics; 1995 Jun; 5(3):143-50. PubMed ID: 7550365
[TBL] [Abstract][Full Text] [Related]
13. Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity.
Leclercq I; Horsmans Y; Desager JP; Pauwels S; Geubel AP
Br J Nutr; 1999 Oct; 82(4):257-62. PubMed ID: 10655974
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of liver function in liver diseases using drugs as indicators].
Tanaka E; Yasuhara H
J Toxicol Sci; 1997 Aug; 22(3):APP 79-87. PubMed ID: 9379499
[No Abstract] [Full Text] [Related]
15. Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humans.
Berthou F; Goasduff T; Lucas D; Dréano Y; Le Bot MH; Ménez JF
Pharmacogenetics; 1995 Apr; 5(2):72-9. PubMed ID: 7663531
[TBL] [Abstract][Full Text] [Related]
16. Assessment of liver metabolic function. Clinical implications.
Brockmöller J; Roots I
Clin Pharmacokinet; 1994 Sep; 27(3):216-48. PubMed ID: 7988103
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cytochrome P450 2E1 activity by the [14C]nitrosodimethylamine breath test.
Bastien MC; Villeneuve JP
Can J Physiol Pharmacol; 1998; 76(7-8):756-63. PubMed ID: 10030456
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the impact of Polygonum capitatum, a traditional Chinese herbal medicine, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs.
Zheng L; Lu Y; Cao X; Huang Y; Liu Y; Tang L; Liao SG; Wang AM; Li YJ; Lan YY; Wang YL
J Ethnopharmacol; 2014 Dec; 158 Pt A():276-82. PubMed ID: 25446640
[TBL] [Abstract][Full Text] [Related]
19. 13C-breath tests in the study of microsomal liver function.
Nista EC; Fini L; Armuzzi A; Candelli M; Zocco MA; Cazzato IA; Merra G; Finizio R; Miele L; Grieco A; Gasbarrini G; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2004; 8(1):33-46. PubMed ID: 15209153
[TBL] [Abstract][Full Text] [Related]
20. Microsomal function in hepatitis B surface antigen healthy carriers: assessment of cytochrome P450 1A2 activity by the 14C-caffeine breath test.
Horsmans Y; De Koninck X; Geubel AP; Pauwels S
Pharmacol Toxicol; 1995 Oct; 77(4):247-9. PubMed ID: 8577634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
